Skip to Content
  • Previous Rank-
  • Revenue 3 Yr Annual Growth Rate27%
  • Revenue 3 Yr Growth Rank52
  • EPS 3 Yr Annual Growth Rate34%
  • EPS 3 Yr Growth Rank57
  • Total Return 3 Yr Annual Rate25%
  • Total Return 3 Yr Rank
    48

The world’s only anthrax vaccine, BioThrax, brought in some 55% of revenues for this manufacturer of drugs to protect against bioterrorism and other threats.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Location
Gaithersburg, Md.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak-
Years on List1
CEO
Daniel Abdun-Nabi
Websitehttp://www.emergentbiosolutions.com
Revenue and net income for the four quarters ended on or before April 30, 2016.!Total return for the period ended June 30, 2016.

Revenue, Net Income

Revenue Past Four Quarters ($M)$570
Net Income Past Four Quarters ($M)$88

Growth Rates and Ranks

Revenue 3 Yr Growth Rank52
EPS 3 Yr Annual Growth Rate34%
EPS 3 Yr Growth Rank57
Total Return 3 Yr Annual Rate25%
Total Return 3 Yr Rank
48